Microbiota metabolite butyrate differentially regulates Th1 and Th17 cells' differentiation and function in induction of colitis
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Background: How the gut microbiota regulates intestinal homeostasis is not completely clear. Gut microbiota metabolite short-chain fatty acids (SCFAs) have been reported to regulate T-cell differentiation. However, the mechanisms underlying SCFA regulation of T-cell differentiation and function remain to be investigated. Methods: CBir1, an immunodominant microbiota antigen, transgenic T cells were treated with butyrate under various T-cell polarization conditions to investigate butyrate regulation of T-cell differentiation and the mechanism involved. Transfer of butyrate-treated CBir T cells into Rag1-/- mice was performed to study the in vivo role of such T cells in inducing colitis. Results: Although butyrate promoted Th1 cell development by promoting IFN-γ and T-bet expression, it inhibited Th17 cell development by suppressing IL-17, Rorα, and Rorγt expression. Interestingly, butyrate upregulated IL-10 production in T cells both under Th1 and Th17 cell conditions. Furthermore, butyrate induced T-cell B-lymphocyte-induced maturation protein 1 (Blimp1) expression, and deficiency of Blimp1 in T cells impaired the butyrate upregulation of IL-10 production, indicating that butyrate promotes T-cell IL-10 production at least partially through Blimp1. Rag1-/- mice transferred with butyrate-treated T cells demonstrated less severe colitis, compared with transfer of untreated T cells, and administration of anti-IL-10R antibody exacerbated colitis development in Rag-/- mice that had received butyrate-treated T cells. Mechanistically, the effects of butyrate on the development of Th1 cells was through inhibition of histone deacetylase but was independent of GPR43. Conclusions: These data indicate that butyrate controls the capacity of T cells in the induction of colitis by differentially regulating Th1 and Th17 cell differentiation and promoting IL-10 production, providing insights into butyrate as a potential therapeutic for the treatment of inflammatory bowel disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Butyrate can also promote the production of IL-10 by regulating the differentiation of Th1 and Th17 cells and inducing the expression of mature protein 1 (Blimp1), ameliorating colonic inflammation and maintaining intestinal homeostasis.189”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [189]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells
Furusawa, Y., Obata, Y., Fukuda, S., Endo, T. A., Nakato, G., Takahashi, D., Nakanishi, Y., Uetake, C., Kato, K., Kato, T., et al. (2013) · Nature · doi:10.1038/nature12721 · Cited by 5,549
The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic T reg Cell Homeostasis
Smith, P. M., Howitt, M. R., Panikov, N., Michaud, M., Gallini, C. A., Bohlooly-Y, M., Glickman, J. N., & Garrett, W. S. (2013) · Science · doi:10.1126/science.1241165 · Cited by 5,413
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
Arpaia, N., Campbell, C., Fan, X., Dikiy, S., van der Veeken, J., deRoos, P., Liu, H., Cross, J. R., Pfeffer, K., Coffer, P. J., et al. (2013) · Nature · doi:10.1038/nature12726 · Cited by 4,838
A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment
Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G., & Glimcher, L. H. (2000) · Cell · doi:10.1016/s0092-8674(00)80702-3 · Cited by 3,589
Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis
Trompette, A., Gollwitzer, E. S., Yadava, K., Sichelstiel, A. K., Sprenger, N., Ngom-Bru, C., Blanchard, C., Junt, T., Nicod, L. P., Harris, N. L., et al. (2014) · Nature Medicine · doi:10.1038/nm.3444 · Cited by 2,862
The role of short chain fatty acids in health and disease
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00003-9 · Cited by 2,425
T Helper 17 Lineage Differentiation Is Programmed by Orphan Nuclear Receptors RORα and RORγ
Yang, X. O., Pappu, B. P., Nurieva, R., Akimzhanov, A., Kang, H. S., Chung, Y., Ma, L., Shah, B., Panopoulos, A. D., Schluns, K. S., et al. (2008) · Immunity · doi:10.1016/j.immuni.2007.11.016 · Cited by 1,605
Park, J., Kim, M., Kang, S. G., Jannasch, A. H., Cooper, B., Patterson, J., & Kim, C. H. (2015) · Mucosal Immunology · doi:10.1038/mi.2014.44 · Cited by 1,307
Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases
Sun, M., Wu, W., Liu, Z., & Cong, Y. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-016-1242-9 · Cited by 1,047
Self-citationDietary fatty acids directly impact central nervous system autoimmunity via the small intestine
Haghikia, A., Jörg, S., Duscha, A., Berg, J., Manzel, A., Waschbisch, A., Hammer, A., Lee, D.-H., May, C., Wilck, N., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.007 · Cited by 927
Research works printed but not linked: 2
- 33. Smith PM, Howitt MR, Panikov N, et al. The microbial metabolites, short-chain fatty acids, regulate colonic treg cell homeostasis. Science. 2013;341:569–573. [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
- 34. Arpaia N, Campbell C, Fan X, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013;504:451–455. [DOI] [PMC free article] [PubMed] [Google Scholar] Associated Data This section collects any data citations, data availability statements, or supplementary materials included in this article. · DOI · Paper page
Cited by
Short-chain fatty acids: Linking diet, the microbiome and immunity
Mann, E. R., Lam, Y. K., & Uhlig, H. H. (2024) · Nature reviews. Immunology · doi:10.1038/s41577-024-01014-8 · Cited by 1,595
“Butyrate favours T H 1 cell differentiation by upregulating T-bet expression and downregulating the expression of RORγt and other T H 17 cell-associated transcription factors 88 .”
Yang, W., Yu, T., Huang, X., Bilotta, A. J., Xu, L., Lu, Y., Sun, J., Pan, F., Zhou, J., Zhang, W., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18262-6 · Cited by 1,042
Self-citationYang, W., & Cong, Y. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00661-4 · Cited by 679
Self-citationRosser, E. C., Piper, C. J. M., Matei, D. E., Blair, P. A., Rendeiro, A. F., Orford, M., Alber, D. G., Krausgruber, T., Catalan, D., Klein, N., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.03.003 · Cited by 579
“SCFAs are a potent class of immune-modulatory compounds with the capacity to modulate Treg, T helper 17 (Th17) cells, and macrophage differentiation in the gut and periphery (Arpaia et al., 2013; Chen et al., 2019; Schulthess et al., 2019).”
BackgroundPathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome
Lv, R., Liu, X., Zhang, Y., Dong, N., Wang, X., He, Y., Yue, H., & Yin, Q. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01496-3 · Cited by 477
García-Montero, C., Fraile-Martínez, O., Gómez-Lahoz, A. M., Pekarek, L., Castellanos, A. J., Noguerales-Fraguas, F., Coca, S., Guijarro, L. G., García-Honduvilla, N., Asúnsolo, A., et al. (2021) · Nutrients · doi:10.3390/nu13020699 · Cited by 431
Gut microbiota-derived short chain fatty acids are potential mediators in gut inflammation
Akhtar, M., Chen, Y., Ma, Z., Zhang, X., Shi, D., Khan, J. A., & Liu, H. (2022) · Animal Nutrition · doi:10.1016/j.aninu.2021.11.005 · Cited by 363
Epigenetic regulation by gut microbiota
Woo, V., & Alenghat, T. (2022) · Gut Microbes · doi:10.1080/19490976.2021.2022407 · Cited by 319
“Another study similarly found that butyrate promoted Th1, but suppressed Th17 polarization from naïve T cells in culture and in vivo by inhibiting HDAC activity independently from GPR43 activation to induce expression of T-bet and the anti-inflammatory cytokine IL-10.(83) Congruent with enhanced IL-10 in response to b…”
BackgroundResultBiological Function of Short-Chain Fatty Acids and Its Regulation on Intestinal Health of Poultry
Liu, L., Li, Q., Yang, Y., & Guo, A. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.736739 · Cited by 310
“Moreover a research has also proven the ability of butyrate to alleviate gut inflammation by differentially controling differentiation of Th1 and Th17 and enhancing IL-10 production (83).”
BackgroundThe role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Recharla, N., Geesala, R., & Shi, X.-Z. (2023) · Nutrients · doi:10.3390/nu15102275 · Cited by 256
“[58] found that butyrate enhanced Th1 differentiation by promoting IFN-γ levels and T-bet expression in healthy conditions, but inhibited Th1 differentiation through IL-10 production and T-bet expression in colonic inflammation.”
BackgroundRegulatory role of short-chain fatty acids in inflammatory bowel disease
Zhang, Z., Zhang, H., Chen, T., Shi, L., Wang, D., & Tang, D. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00869-5 · Cited by 259
Zhang, Z., Tang, H., Chen, P., Xie, H., & Tao, Y. (2019) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-019-0074-5 · Cited by 251
Hiippala, K., Barreto, G., Burrello, C., Diaz-Basabe, A., Suutarinen, M., Kainulainen, V., Bowers, J. R., Lemmer, D., Engelthaler, D. M., Eklund, K. K., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.575455 · Cited by 228
“As O. splanchnicus is a known producer of SCFAs (Werner et al., 1975), these metabolites may have enhanced to some extent the upregulation of IL-10 production in PBMCs (Saemann et al., 2000; Cavaglieri et al., 2003; Chen et al., 2019).”
BackgroundHypertension: Do Inflammation and Immunity Hold the Key to Solving this Epidemic?
Madhur, M. S., Elijovich, F., Alexander, M. R., Pitzer, A., Ishimwe, J., Van Beusecum, J. P., Patrick, D. M., Smart, C. D., Kleyman, T. R., Kingery, J., et al. (2021) · Circulation Research · doi:10.1161/circresaha.121.318052 · Cited by 211
Nagpal, R., Neth, B. J., Wang, S., Mishra, S. P., Craft, S., & Yadav, H. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102950 · Cited by 188
“Butyrate, which was increased by MMKD in these patients with MCI [24], is also known to reduce Th17 cells [82, 83].”
BackgroundMicrobial dysbiosis in the gut drives systemic autoimmune diseases
Mousa, W. K., Chehadeh, F., & Husband, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.906258 · Cited by 185
“A mouse model of T1D has a reduction in IL-22, IL-17A, and IL-23A that is associated with loss of segmented filamentous Frontiers in Immunology 05 bacteria (87).”
BackgroundInfluentialChen, Y., Yang, B., Ross, R. P., Jin, Y., Stanton, C., Zhao, J., Zhang, H., & Chen, W. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05744 · Cited by 185
Psoriatic arthritis from a mechanistic perspective
Schett, G., Rahman, P., Ritchlin, C., McInnes, I. B., Elewaut, D., & Scher, J. U. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00776-6 · Cited by 167
Gut Microbiota Modulation on Intestinal Mucosal Adaptive Immunity
Wang, L., Zhu, L., & Qin, S. (2019) · Journal of Immunology Research · doi:10.1155/2019/4735040 · Cited by 179
“have shown that butyrate controls the T cell capacity in the induction of colitis through differential regulation of Th1 and Th17 cell differentiation and promotion of IL-10 production [14].”
BackgroundProspects for clinical applications of butyrate-producing bacteria
Zhu, L., Zhang, Y., Huang, H.-H., & Lin, J. (2021) · World Journal of Clinical Pediatrics · doi:10.5409/wjcp.v10.i5.84 · Cited by 152
Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression
Lin, L., Zhang, K., Xiong, Q., Zhang, J., Cai, B., Huang, Z., Yang, B., Wei, B., Chen, J., & Niu, Q. (2023) · Journal of Autoimmunity · doi:10.1016/j.jaut.2023.103001 · Cited by 148
Kopczyńska, J., & Kowalczyk, M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1380476 · Cited by 164
Du, H., Yue, S.-Y., Niu, D., Liu, C., Zhang, L., Chen, J., Chen, Y., Guan, Y., Hua, X., Li, C., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915218 · Cited by 152
Man, A. W. C., Zhou, Y., Xia, N., & Li, H. (2020) · Nutrients · doi:10.3390/nu12103054 · Cited by 128
“A recent study also suggests that butyrate is able to control the capacity of T cells by differentially regulating Th1 and Th17 cell differentiation and promoting IL-10 production in the induction of colitis [93].”
BackgroundDiet, microbiota, and the mucus layer: The guardians of our health
Suriano, F., Nyström, E. E. L., Sergi, D., & Gustafsson, J. K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.953196 · Cited by 136
Short chain fatty acids, a possible treatment option for autoimmune diseases
Golpour, F., Abbasi-Alaei, M., Babaei, F., Mirzababaei, M., Parvardeh, S., Mohammadi, G., & Nassiri‐Asl, M. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114763 · Cited by 133
Anderson, G., & Maes, M. H. J. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200131094445 · Cited by 121
Yue, Y., He, Z., Zhou, Y., Ross, R. P., Stanton, C., Zhao, J., Zhang, H., Yang, B. K., & Chen, W. (2020) · Food & Function · doi:10.1039/d0fo02670k · Cited by 116
Wu, J., Li, C., Bai, L., Wu, J., Bo, R., Ye, M., Huang, L., Chen, H., & Rui, W. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.04.055 · Cited by 106
Aghamajidi, A., & Vareki, S. M. (2022) · Cancers · doi:10.3390/cancers14153563 · Cited by 110
Chen, Y., Jin, Y. J., Stanton, C., Ross, R. P., Zhao, J., Zhang, H., Yang, B. K., & Chen, W. (2020) · European Journal of Nutrition · doi:10.1007/s00394-020-02252-x · Cited by 104
Li, W., Zhang, L., Xu, Q., Yang, W., Zhao, J., Ren, Y., Yu, Z., & Ma, L. (2022) · Nutrients · doi:10.3390/nu14051069 · Cited by 106
Self-citationChen, H., Zhang, F., Li, R., Liu, Y., Wang, X., Zhang, X., Xu, C., Li, Y., Guo, Y., & Yao, Q. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109829 · Cited by 107
Maternal prenatal gut microbiota composition predicts child behaviour
Dawson, S. L., O’Hely, M., Jacka, F. N., Ponsonby, A., Symeonides, C., Loughman, A., Collier, F., Moreno‐Betancur, M., Sly, P. D., Burgner, D. P., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103400 · Cited by 114
“In mice, butyrate inhibits Th17 cell development and promotes production of the anti-inflammatory cytokine IL10 [2, 33].”
BackgroundPeng, K., Xiao, S., Xia, S., Li, C.-L., Yu, H., & Yu, Q. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c04456 · Cited by 118
Low Fibre Intake is Associated with Gut Microbiota Alterations in Chronic Heart Failure
Mayerhofer, C. C. K., Kummen, M., Holm, K., Broch, K., Awoyemi, A., Vestad, B., Storm-Larsen, C., Seljeflot, I., Ueland, T., Bohov, P., et al. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12596 · Cited by 107
Gut microbiota as a key regulator of intestinal mucosal immunity
Wang, J., He, M., Yang, M., & Ai, X. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122612 · Cited by 112
Xiang, X., Zheng, H., Wang, R., Chen, H., Xiao, J., Zheng, B., Liu, S., & Ding, Y. (2021) · Marine Drugs · doi:10.3390/md19080456 · Cited by 84
“It has recently been reported that butyrate maintained intestinal homeostasis through anti-inflammatory effects, which had specific immunomodulatory functions and enhanced the overall integrity of the intestinal barrier [20,81].”
BackgroundThe bridge of the gut–joint axis: Gut microbial metabolites in rheumatoid arthritis
Xu, X., Wang, M., Wang, Z., Chen, Q., Chen, X., Xu, Y., Dai, M., Wu, B., & Li, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1007610 · Cited by 105
“(124), butyrate promoted Th1 levels but induced the expression of T box transcription factor (T-bet) and the anti-inflammatory cytokine IL-10 by inhibiting HDAC activity independently of gpr43 activation, thereby suppressing Th17 polarization of naïve T cells in culture and in vivo.”
BackgroundLee, J. G., Lee, J., Lee, A.-R., Jo, S. V., Park, C. H., Han, D. S., & Eun, C. S. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108926 · Cited by 87
Xie, Z., Li, M., Qian, M., Yang, Z., & Han, X. (2022) · Nutrients · doi:10.3390/nu14214475 · Cited by 85
Wang, J., Zhu, G., Sun, C., Xiong, K., Yao, T., Su, Y., & Fang, H. (2020) · Microbial Cell Factories · doi:10.1186/s12934-020-01417-x · Cited by 78
Li, W., Zhou, Q., Lv, B., Li, N., Bian, X., Chen, L., Kong, M., Shen, Y., Zheng, W., Zhang, J., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c08385 · Cited by 88
Self-citationYu, C., Wu, D., Zhu, K., Hou, L., Xiao, H., Ding, T., Liu, D., Ye, X., Linhardt, R. J., & Chen, S. (2021) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2021.118377 · Cited by 79
“Butyrate can regulate the differentiation of intestinal epithelial cells and Th cells (L. Chen et al., 2019).”
BackgroundThe role of the gut microbiota in tumor, immunity, and immunotherapy
Xie, Y., & Liu, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1410928 · Cited by 77
Role of the microbiome and its metabolites in ankylosing spondylitis
Song, Z., Yuan, D., & Zhang, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1010572 · Cited by 76
“Interestingly, butyrate promoted IL-10 production in both cell conditions, thereby controlling the development of colitis (114).”
BackgroundLu, W., Deng, Y., Fang, Z., Zhai, Q., Cui, S., Zhao, J., Chen, W., & Zhang, H. (2021) · Nutrients · doi:10.3390/nu13062010 · Cited by 71
“In addition, the gut microbiota regulates immunity through its metabolites; short-chain fatty acids (SCFAs), products of carbohydrate digestion by gut microbiota, promote T cell differentiation into regulatory T (Treg) cells [15], and this in turn blocks the differentiation of other T cells, such as Th17 cells [16].”
BackgroundWang, J., Hou, Y., Mu, L., Yang, M., & Ai, X. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113570 · Cited by 83
Chen, K., Wang, H., Yang, X., Tang, C., Hu, G., & Gao, Z. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107483 · Cited by 77
Luo, D. Y., Zhou, J., Ruan, S., Zhang, B., Zhu, H., Que, Y., Ying, S., Li, X., Hu, Y., & Song, Z. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07385-7 · Cited by 79
The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy
Wang, M., Yang, G., Tian, Y., Zhang, Q., Liu, Z., & Xin, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183331 · Cited by 74
Self-citationSaadh, M. J., Allela, O. Q. B., Ballal, S., Mahdi, M. S., Chahar, M., Verma, R., Al-Hussein, R. K. A., Adil, M., Jawad, M. J., & Al-Nuaimi, A. M. A. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152398 · Cited by 74
Lv, J., Hao, P., Zhou, Y., Liu, T., Wang, L., Song, C., Wang, Z., Liu, Z., & Liu, Y. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10714-w · Cited by 59
“RORγt, a crucial transcription factor linked to Th17 cell differentiation, is inhibited by SCFAs, particularly butyric and propionic acids [57].”
Self-citationThe Immune System through the Lens of Alcohol Intake and Gut Microbiota
Calleja‐Conde, J., Echeverry‐Alzate, V., Bühler, K., Durán‐González, P., Morales-Garcia, J. A., Segovia‐Rodríguez, L., de Fonseca, F. R., Giné, E., & López‐Moreno, J. J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147485 · Cited by 81
“For example, butyrate stimulated differentiation of T-regulatory cells and increased levels of IL-10 while reducing production of IL-6 and inhibiting the expansion of pro-inflammatory Th17 cells [21].”
BackgroundMosaic theory revised: inflammation and salt play central roles in arterial hypertension
Hengel, F. E., Bénitah, J., & Wenzel, U. O. (2022) · Cellular and Molecular Immunology · doi:10.1038/s41423-022-00851-8 · Cited by 59
“Transferring butyrate-exposed T cells into mice led to the development of an attenuated form of colitis compared to the transfer of nonbutyrate-exposed T cells [151, 153].”
BackgroundMitigation of Osteoclast‐Mediated Arthritic Bone Remodeling By Short Chain Fatty Acids
Yang, K. L., Mullins, B. J., Lejeune, A., Ivanova, E. N., Shin, J., Bajwa, S., Possemato, R., Cadwell, K., Scher, J. U., & Koralov, S. B. (2023) · Arthritis & Rheumatology · doi:10.1002/art.42765 · Cited by 57
Henry, N., Frank, J. A., McLouth, C. J., Trout, A. L., Morris, A. J., Chen, J., Stowe, A. M., Fraser, J. F., & Pennypacker, K. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.797302 · Cited by 53
“9 22 (42) Moderate Stroke (5-14) 16 (40) 30-34.”
InfluentialAloo, S. O., & Oh, D. (2022) · Antioxidants · doi:10.3390/antiox11020333 · Cited by 51
Vitamin B5 rewires Th17 cell metabolism via impeding PKM2 nuclear translocation
Chen, C., Zhang, W., Zhou, T., Liu, Q., Han, C., Huang, Z., Chen, S., Mei, Q., Zhang, C., Zhang, K., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111741 · Cited by 58
Gut microbiota modulates lung fibrosis severity following acute lung injury in mice
Chioma, O. S., Mallott, E. K., Chapman, A., Amburg, J. C. V., Wu, H., Shah-Gandhi, B., Dey, N., Kirkland, M. E., Piazuelo, M. B., Johnson, J. E., et al. (2022) · Communications Biology · doi:10.1038/s42003-022-04357-x · Cited by 54
“The species negatively correlated with immune activation include Lactobacillus species, which have been shown to produce butyrate that dampens Th17 polarization 18,19 .”
Zhao, Y., Chen, J., Qin, Y., Yuan, J., Zheng, Y., Ma, R., Liu, F., & Zhao, J. (2025) · Journal of Nutrition and Metabolism · doi:10.1155/jnme/8870958 · Cited by 57
“Similarly, butyrate restrains hyperactive immune responses during T17 diferentiation by inducing Blimp-1 and IL-10 [55].”
Maternal microbiome in preeclampsia pathophysiology and implications on offspring health
Ishimwe, J. A. (2021) · Physiological Reports · doi:10.14814/phy2.14875 · Cited by 45
“For example, inhibiting TMAO production by 3,3- Dimethyl- 1- butanol ameliorated endothelial function and hypertension in the RUPP model (Chen et al., 2019).”
BackgroundYou, S., Liu, X., Xu, G., Ye, M., Bai, L., Lin, R.-X., Sha, X., Liang, L., Huang, J. C., Zhou, C., et al. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104353 · Cited by 45
Airway microbiome-immune crosstalk in chronic obstructive pulmonary disease
Kayongo, A., Robertson, N. M., Siddharthan, T., Ntayi, M. L., Ndawula, J. C., Sande, O. J., Bagaya, B. S., Kirenga, B., Mayanja‐Kizza, H., Joloba, M. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1085551 · Cited by 60
Yang, W., Yu, T., Liu, X., Yao, S., Khanipov, K., Golovko, G., Olivares–Villagómez, D., & Cong, Y. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2363020 · Cited by 50
“Consistent with our previous study, 13 we found that butyrate-pretreated WT Th1 cells induced less severe colitis and lower levels of TNF-α in the intestine in Rag1 −/− mice than control WT Th1 cells (Figure 2E–”
BackgroundResultSelf-citationThe Gut Microbiota: How Does It Influence the Development and Progression of Liver Diseases
Kanmani, P., Kanmani, S., & Kim, H. (2020) · Biomedicines · doi:10.3390/biomedicines8110501 · Cited by 51
“On the other hand, it affected TH17 cell development by decreasing IL-17, Rorα, and Rorγt production in mice [45].”
BackgroundGut microbiota: a promising new target in immune tolerance
Almansour, N., Al‐Rashed, F., Choudhry, K., Alqaderi, H. E., Sindhu, S. T. A. K., Al‐Mulla, F., & Ahmad, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1607388 · Cited by 59
Klasen, C., Meyer, A., Wittekind, P. S., Waqué, I., Nabhani, S., & Kofler, D. M. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1948-1 · Cited by 42
Han, C., Wang, Y., Liu, R., Ran, B., & Li, W. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113174 · Cited by 41
Chen, K., Wang, H., Yang, Y., Tang, C., Sun, X., Zhou, J., Liu, S., Li, Q., Zhao, L., & Gao, Z. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02299-5 · Cited by 49
“This modulation results in a reduction in the proliferation and differentiation of Th17 cells, consequently leading to decreased levels of interleukin-17 (IL-17) [46, 47].”
Ma, J., Long, S., Wang, J., Gao, J., & Piao, X. (2022) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-021-00670-3 · Cited by 45
“Mechanistically, organic acids increased the level of IL-10 primarily by differentially moderating Th1 and Th17 cell differentiation [42] or increase the concentration of IL-10 in T cells and regulatory B cells by inhibiting histone deacetylases and regulating the mammalian target of rapamycin [43,…”
BackgroundYang, W., Yu, T., & Cong, Y. (2022) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbac018 · Cited by 45
Self-citationAlhouayek, M., Ameraoui, H., & Muccioli, G. G. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158854 · Cited by 44
Prebiotic effects of goji berry in protection against inflammatory bowel disease
Sun, Q., Du, ., Kang, Y., & Zhu, M. J. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.2015680 · Cited by 42
Jamka, M., Kokot, M., Kaczmarek, N., Bermagambetova, S., Nowak, J. K., & Walkowiak, J. (2020) · Complementary Medicine Research · doi:10.1159/000512952 · Cited by 43
Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models
Vieujean, S., Caron, B., Haghnejad, V., Jouzeau, J., Netter, P., Heba, A.-C., Ndiaye, N. C., Moulin, D., Barreto, G., Danese, S., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147611 · Cited by 48
“Drug Activity EpigeneticMechanism Tissue/Cells Mechanism Model Author Herb-partitioned moxibustion (HPM) Anti-inflammatory activity miR-184 and miR-490-5p Colonic tissue HPM regulates miR-184 and miR-490-5p expression, act on the transcription of their target genes to regulate inflammatory signaling pathways, and atte…”
BackgroundInfluentialThe gut microbiome: A line of defense against tuberculosis development
Yu, Z., Shen, X., Wang, A., Hu, C., & Chen, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1149679 · Cited by 37
From gut to placenta: understanding how the maternal microbiome models life-long conditions
Ruiz-Triviño, J., Álvarez, D., J., Á. P. C., & Álvarez, Á. M. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1304727 · Cited by 47
“Butyrate regulates the differentiation of Th17 and Th1 cells (62); maternal retinoic acid (RA) induces the generation of fetal type 3 innate lymphoid cells and, therefore, secondary lymphoid organs development (63); and Clostridia spp. in the maternal gut can modulate the RA levels by suppressing…”
BackgroundLin, X., Peng, Y., Guo, Z., He, W., Guo, W., Feng, J., Lin, L., Liu, Q., & Xu, P. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05332-x · Cited by 41
“Short-chain fatty acids (SCFAs) are among the most well-characterized microbiota-derived metabolites, serving as potent immune-modulatory compounds that modulate the inflammatory responses of lymphocytes, neutrophils, and macrophage in both the periphery and the CNS [3, 4].”
Epigenome-metabolome-microbiome axis in health and IBD
Amatullah, H., & Jeffrey, K. L. (2020) · Current Opinion in Microbiology · doi:10.1016/j.mib.2020.08.005 · Cited by 38
“prausnitzii, administration in vivo alleviated colitis [94,97].”
Sumbria, D., Berber, E., & Rouse, B. T. (2020) · Journal of Virology · doi:10.1128/jvi.02056-20 · Cited by 34
“function of these cells by effects on Rorgt and STAT3 expression (40, 41).”
BackgroundPhenotypic heterogeneity in psoriatic arthritis: towards tissue pathology-based therapy
Najm, A., Goodyear, C. S., McInnes, I. B., & Siebert, S. (2023) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00874-5 · Cited by 41
Guo, M., Liu, X., Tan, Y., Kang, F., Zhu, X., Fan, X., Wang, C., Wang, R., Liu, Y., Qin, X., et al. (2021) · Food & Function · doi:10.1039/d1fo01351c · Cited by 36
Chen, Y., Li, X., Yang, M., Chen, J., He, Z., Zhou, S., Ruan, P., Wang, Y., Tang, C., Pan, W., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103422 · Cited by 42
“In addition, SCFAs play an anti-inflammatory role by regulating T cell differentiation [71,72], which is consistent with the negative correlation we observed.”
Exacerbation of Chikungunya Virus Rheumatic Immunopathology by a High Fiber Diet and Butyrate
Prow, N. A., Hirata, T. D. C., Tang, B., Larcher, T., Mukhopadhyay, P., Alves, T. L., Le, T. T., Gardner, J., Poo, Y. S., Nakayama, E., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02736 · Cited by 33
Xiao, J., Guo, X., & Wang, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1385907 · Cited by 36
Gut-lung axis in allergic asthma: microbiota-driven immune dysregulation and therapeutic strategies
Lv, J., Zhang, Y., Liu, S., Wang, R., & Zhao, J. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1617546 · Cited by 39
Rodríguez, M. P., Vega‐Magaña, N., García‐Benavides, L., Nuño, J., Gutiérrez-Silerio, G. Y., González‐Hernández, L. A., Andrade-Villanueva, J. F., del Toro‐Arreola, S., Pereira-Suárez, A. L., & Bueno‐Topete, M. R. (2021) · Journal of Applied Microbiology · doi:10.1111/jam.15135 · Cited by 34
Feng, Y., Pan, M., Li, R., He, W., Chen, Y., Xu, S., Chen, H., Xu, H., & Lin, Y. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155812 · Cited by 28
Atopic Dermatitis and Psoriasis: Similarities and Differences in Metabolism and Microbiome
Chen, Y., Peng, C., Zhu, L., Wang, J., Cao, Q., Chen, X., & Li, J. (2024) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-024-08995-3 · Cited by 29
“However, SCFAs reduce the transcription of IL-17 and inhibit Th17 cells while elevating the transcription of IL-10 and Foxp3, thereby alleviating imiquimod-induced inflammation [191, 192].”
Microbiota-dependent metabolites – New engine for T cell warriors
Tang, Y., Fu, A., Wang, L., & Ge, Q. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2523815 · Cited by 31
“71 Further blockade of IL-10 signaling exacerbates colitis, underscoring IL-10‘s critical role in maintaining intestinal homeostasis.”
InfluentialSong, J., Chen, Y., Lv, Z., Taoerdahong, H., Li, G., Li, J., Zhao, X., Xiaoyan, J., & Chang, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128937 · Cited by 27
Butyrate Inhibits Dendritic Cell Activation and Alleviates Periodontitis
Wu, L., Luo, Z., Chen, Y., Yan, Z., Fu, J., Jiang, Y., Xu, J., & Liu, Y. (2023) · Journal of Dental Research · doi:10.1177/00220345231187824 · Cited by 28
“Studies have demonstrated that butyrate is a critical mediator in the regulation of host metabolism (Chen et al. 2019; Schulthess et al. 2019; Zhang et al. 2021).”
BackgroundChen, H., Li, H., & Liu, Z. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820935188 · Cited by 30
Self-citationRecent Metabolic Advances for Preventing and Treating Acute and Chronic Graft Versus Host Disease
Mohamed, F. A., Thangavelu, G., Rhee, S. Y., Sage, P. T., O’Connor, R. S., Rathmell, J. C., & Blazar, B. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.757836 · Cited by 29
Bansal, R., Park, H., Taborda, C., Gordillo, C. A., Mapara, M. Y., Assal, A., Uhlemann, A., & Reshef, R. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.12.015 · Cited by 32
Zhang, L., Ko, C., & Zeng, Y.-M. (2022) · Nature and Science of Sleep · doi:10.2147/nss.s354742 · Cited by 26
Astragalus membranaceus as a Drug Candidate for Inflammatory Bowel Disease: The Preclinical Evidence
Hou, M., Leng, Y., Shi, Y., Tan, Z., & Min, X. (2023) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x23500684 · Cited by 27
Sheng, Y., Li, H., Liu, M., Xie, B., Wei, W. Z., Wu, J., Meng, F., Wang, H. Y., & Chen, D. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz097 · Cited by 25
Metadata
- Authors
- Chen, L., Sun, M., Wu, W., Yang, W., Huang, X., Xiao, Y., Ma, C., Xu, L., Yao, S., Liu, Z., & Cong, Y.
- Affiliations
- Tongji University (CN)
- The University of Texas Medical Branch at Galveston (US)
- Corresponding author
- Liu, Zhanju
- Cong, Yingzi
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2019-03-27
- Volume
- 25
- Issue
- 9
- Pages
- 1450-1461
- ISSN
- 1078-0998 (ISSN-L)
- 1536-4844
- PMC
- PMC6701512
- OpenAlex
- W2925756170
- Semantic Scholar
- 0556df74581e4c2cb792adf373abb7fd1ef76b19
- Cited by
- 231
- References
- 32
- Citations by year
- 2026: 36 · 2025: 47 · 2024: 43 · 2023: 22 · 2022: 29 · 2021: 31 · 2020: 17 · 2019: 6
- FWCI
- 6.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Inflammatory Bowel Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (DK098370, DK105585, DK112436)
- John Sealy Memorial Endowment Fund
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Keywords
- butyrate, short-chain fatty acids
- MeSH terms
- Gastrointestinal Microbiome, T-bet Transcription Factor, Animals, Butyrates, Cell Differentiation, Colitis, Interferon-gamma, Intestinal Mucosa, Mice, Inbred C57BL, Mice, Transgenic, Interleukin-10, Th1 Cells, Interleukin-17, T-Box Domain Proteins, Mice, Nuclear Receptor Subfamily 1, Group F, Member 3, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.